Your browser doesn't support javascript.
loading
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?
Beresniak, Ariel; Napoli, Christian; Oxford, John; Daruich, Alejandra; Niddam, Laurent; Duru, Gérard; Tozzi, Alberto E; Atti, Marta Ciofi Degli; Dupont, Danielle; Rizzo, Caterina; Bremond-Gignac, Dominique.
Afiliação
  • Beresniak A; Data Mining International, Geneva Business Terminal, Route de Pré-Bois, 14, 1216, Geneva, Switzerland. aberesniak@datamining-international.com.
  • Napoli C; Department of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
  • Oxford J; Queen Mary College, London, UK.
  • Daruich A; University Hospital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, AP-HP, Paris University, Paris, France.
  • Niddam L; Research Centre Cordeliers, INSERM, UMRS1138, Team 17, Sorbonne Paris Cité University, Paris, France.
  • Duru G; Niddam European Community Lawyer, Budapest, Hungary.
  • Tozzi AE; Data Mining International, Geneva Business Terminal, Route de Pré-Bois, 14, 1216, Geneva, Switzerland.
  • Atti MCD; IRCCS, Bambino Gesù Children's Hospital, Rome, Italy.
  • Dupont D; IRCCS, Bambino Gesù Children's Hospital, Rome, Italy.
  • Rizzo C; Data Mining International, Geneva Business Terminal, Route de Pré-Bois, 14, 1216, Geneva, Switzerland.
  • Bremond-Gignac D; IRCCS, Bambino Gesù Children's Hospital, Rome, Italy.
Cost Eff Resour Alloc ; 21(1): 30, 2023 May 15.
Article em En | MEDLINE | ID: mdl-37189126
ABSTRACT

BACKGROUND:

The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the cost-effectiveness of existing public health measures against human influenza pandemics. A dataset has been specifically collected in the frame of the Italian health system. As most of interventions against human influenza are relavant against other respiratory diseases pandemics, potential interests in COVID-19 are discussed.

METHODS:

Ten public health measures against human influenza pandemics pandemic were selected to be also relevant to other respiratory virus pandemics such as COVID 19 individual (hand washing, using masks), border control (quarantine, fever screening, border closure), community infection (school closure, class dismissal, social distancing, limitation of public transport), reduction of secondary infections (implementation of antibiotic therapy guidelines), pneumococcal vaccination for at-risk people, development of Intensive Care Unit (ICU) capacity, implementation of life support equipments in ICU, screening interventions, vaccination programs targeting health professional and targeting general population.

RESULTS:

Using mortality reduction as effectiveness criteria, the most cost-effective strategies are "reduction of secondary infections" and "implementation of life support equipment in ICU". The least cost-effective option whatever the level of pandemic events are screening interventions and mass vaccination.

CONCLUSIONS:

A number of intervention strategies against human influenza pandemics appears relevant against every respiratory virus, including the COVID-19 event. Measures against pandemics should be considered according to their expected effectiveness but also their costs for the society because they impose substantial burden to the population, confirming the interest of considering cost-effectiveness of public health measures to enlighten decision making.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça